Cite Filings / CGEM / 0001950047-25-010561
Feed Companies Filings Check
Sign in
Cite Filings

Pages

  • Feed
  • Companies
  • Filings
  • Check a claim

Account

  • Sign in
  • Create an account
Support (opens in new tab)
144

Sale of Securities

Cullinan Therapeutics, Inc. · Filed 2025-12-19 · Acc 0001950047-25-010561

Documents 1

  • 144 Sale of Securities , xsl144X01/primary_doc.xml

Around this filing

  • 2026-01-22 144 Sale of Securities
  • 2025-12-19 144 Sale of Securities
  • 2025-12-19 4 Chief Legal Officer sold 3,480 shares at $9.67 ($33,652)
  • 2025-12-19 4 Chief Medical Officer sold 4,632 shares at $9.67 ($44,791)
  • 2025-12-19 4 Chief Scientific Officer sold 2,898 shares at $9.67 ($28,024)
  • 2025-12-16 4 Chief Scientific Officer sold 3,143 shares at an average $12.23 ($38,433)
  • 2025-12-15 144 Sale of Securities

Link to a passage

At least 12 characters, not counting spaces, so the link points to one passage.

External

  • SEC EDGAR (opens in new tab)
Loading xsl144X01/primary_doc.xml…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…